Phytosterol Intake and Dietary Fat Reduction are Independent and Additive in their Ability to Reduce Plasma LDL Cholesterol

Food Components and Health Laboratory, Beltsville Human Nutrition Research Center, USDA, ARS, Beltsville, MD, USA.
Lipids (Impact Factor: 1.85). 03/2009; 44(3):273-81. DOI: 10.1007/s11745-008-3278-y
Source: PubMed


We studied the interrelationship of diet and plant sterols (PS) on plasma lipids, lipoproteins and carotenoids. Mildly hypercholesterolemic men (n = 13) and postmenopausal women (n = 9) underwent four randomized, crossover, double-blind, controlled feeding periods of 23 days each. The design consisted of two levels of PS (0 and 3.3 g/day) and two background diets having fat content either typical of the American diet (total and saturated fat at 33.5 and 13.2% of energy, respectively), or a Step 1 type of diet (total and saturated fat at 26.4 and 7.7% of energy, respectively). Plasma total cholesterol (TC), high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, Apo A1 and Apo B were 4.3, 5.3, 4.5, 2.8 and 2.5% lower, respectively (P <or= 0.0001; <0.0001, 0.0016, 0.0006, and 0.0069), with the Step 1 diet than with the typical American diet. Diet had no effect on TC/HDL cholesterol (P = 0.1062). Plant sterol intake lowered TC, LDL cholesterol, and Apo B by 9.0, 12.4 and 6.1% and TC/HDLC by 9.6% (P <or= 0.0001 for all), respectively, without affecting HDL cholesterol and Apo A1 (P = 0.2831 and 0.732). The PS effect in lowering plasma TC and LDL cholesterol was independent of and additive to the effect due to dietary fat reduction. Responses of plasma carotenoids to PS intake were consistent with the literature.

Download full-text


Available from: Matt Kramer, Jan 13, 2014
  • Source
    • "Denke [49] concluded that the lack of LDL cholesterol lowering seen in response to sitostanol capsules may have been due to the experimental diet being low cholesterol (<200 mg/day) or due to the formulation of the capsule which may not have mixed with the intestinal contents. It has previously been shown that phytosterol supplementation can reduce LDL-cholesterol when supplemented while consuming a low cholesterol diet [50] [51] [52], therefore, the formulation of the capsule is more likely to have contributed to the lack of effect seen by Denke et al. McPherson et al. [53] also reported non-significant reductions in LDL-cholesterol in one arm of their study. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Phytosterols are a family of compounds similar to cholesterol which have been shown to lower cholesterol levels when supplemented in the diet. A daily dose of 2–3 g of phytosterols has been shown to reduce LDL-cholesterol levels by 5–15%. Phytosterol supplementation can be undertaken using phytosterol enriched functional foods or nutraceutical preparations. The type of phytosterol supplemented, such as plant sterol or saturated plant stanol appear to be equally effective in lowering cholesterol levels. Phytosterols, whether in esterified or free form have both been shown to lower cholesterol levels, with esterified phytosterol formulations having a greater number of clinical trials demonstrating efficacy. The functional food or nutraceutical matrix which is used to deliver supplemental phytosterols can significantly affect cholesterol lowering efficacy. Effective cholesterol lowering by phytosterols depends on delivery of phytosterols to the intestine in a form which can compete with cholesterol for absorption. New phytosterol functional food and nutraceuticals products should always be tested to demonstrate adequate delivery of phytosterol dose and effective total and LDL-cholesterol lowering. Phytosterol products which do not effectively lower cholesterol will negatively impact the perception and use of phytosterols, and must not be allowed on the marketplace.
    Full-text · Article · Dec 2011 · European Journal of Lipid Science and Technology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The R&D program described in this paper focuses on an improvement of the SLAC linac designed to extract and study a 9 GeV electron beam under stringent control of energy, energy spread, emittance, optical parameters, and timing. The extraction system begins with an on-axis pulsed magnet, followed by a magnetic lattice and diagnostic equipment required for the measurement and optimization of the above beam qualities. Design, construction, and installation of this system is the first step in the development of the overall PEP-II e<sup>±</sup> injection system. This system is required to fill 1658 bunches of 9 GeV electrons (0.99 A stored) and 3.1 GeV positrons (2.14 A stored) in two separate rings in a total of about 6 minutes from zero ring current (i.e., full-fill mode, 0 to 100%) or in about 3 minutes from 80% ring current (i.e., topping-off mode, 80 to 100%). This unprecedented rate of filling can be met by a judicious use of the SLC linac, damping rings, and positron source
    Full-text · Conference Paper · Jun 1993
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We present frequency domain bootstrap-based signal denoising schemes applicable to real-valued non-Gaussian signals embedded in additive white Gaussian noise. The two proposed schemes separate the noisy signal into frequency bands using Fourier or wavelet transforms. Each frequency band is tested for Gaussianity by evaluating its kurtosis. The bootstrap method is applied to increase the reliability of the kurtosis estimate. Noise effects are minimized using thresholding schemes on the frequency bands that are estimated to be Gaussian. The estimate of the signal is obtained by applying the appropriate inverse transform to the modified data. The denoising schemes are tested using a stationary and non-stationary signal type. Results show that FFT-based denoising schemes perform better than WT-based denoising schemes on the stationary sinusoidal signal, whereas WT-based schemes outperform FFT-based schemes on chirp outperforms soft thresholding.
    Preview · Conference Paper · Dec 2002
Show more